"Awake and Ablated": First experience with a balloon-in-basket PFA system without propofol

“清醒消融术”:首次尝试使用无丙泊酚的球囊篮式PFA系统进行PFA治疗。

阅读:1

Abstract

BACKGROUND: Pulsed field ablation (PFA) is a novel technique for pulmonary vein isolation (PVI) in atrial fibrillation, offering myocardial selectivity and a favorable safety profile. The balloon-in-basket (BiB)-PFA system enables circumferential PVI with optimized tissue contact. PFA is typically performed under deep sedation or general anesthesia, increasing procedural risk and logistical burden. OBJECTIVE: This study evaluated the safety, feasibility, and patient experience of BiB-PVI under conscious sedation, keeping patients awake and avoiding routine use of propofol. METHODS: Consecutive patients undergoing de novo PVI were prospectively enrolled. Conscious sedation included fentanyl, midazolam, metamizole, and lidocaine; propofol was used for direct-current cardioversion only. Patient experience was assessed via structured questionnaires at 3 time points: during ablation and 1 hour and 1 day after the procedure. Pain, dyspnea, and anxiety were rated on numeric rating scales (0-10); satisfaction and recommendation were rated on visual analog scales (0%-100%). RESULTS: 14 patients (86% male; age 70.6 ± 9.8 years; BMI 27.7 ± 3.7 kg/m(2)) were included. Procedure duration was 54.5 minutes (38.3, 60.8); LA dwell time was 23 minutes (19.5, 34.8). 2.5 PFA applications (2.0, 4.0) were delivered per vein (left superior pulmonary vein 2.5; left inferior pulmonary vein 2.5; right inferior pulmonary vein 2.5; right superior pulmonary vein 2.5). Additional ablation strategies were performed owing to the interventionist's preference. No escalation to deep sedation was required. Pain was 6.5 (4.3, 8.0), decreasing to 2.0 after ablation and on day 1 (P = .002/.001). Dyspnea and anxiety remained low. Satisfaction reached 95% (90, 100) and recommendation 100% (90, 100), remaining high throughout follow-up. CONCLUSION: PFA using the BiB-PFA system under conscious sedation is safe, feasible, and well tolerated, enabling streamlined workflows with high patient satisfaction.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。